Gutiérrez-Cabano C A
Department of Surgical Pathology II, Faculty of Medical Sciences, National University of Rosario, Argentina.
Dig Dis Sci. 1994 Sep;39(9):1864-71. doi: 10.1007/BF02088116.
Effects of necrotizing agents, blockers of gastric motility, and mild irritants on gastric mucosa and gastric motility were investigated in conscious rats. Gastric motor activity was recorded using a miniature balloon placed in the glandular part of the stomach, which was connected to a pressure transducer and polygraph. Necrotizing agents, such as 96% ethanol, 0.6 N hydrochloric acid, 0.2 N sodium hydroxide, or 4 M sodium chloride, were given intragastrically through a fistula on the forestomach. One milliliter of these agents produced hemorrhagic bandlike lesions in the corpus mucosa along the long axis of the stomach with the occurrence of a complete inhibition of gastric motility (smooth muscle relaxation). Blockers of gastric motility alone, such as subcutaneous papaverine HCl (50 mg/kg), and intraperitoneal verapamil (20 mg/kg), or mild irritants (1 ml/rat, orally) such as 20% ethanol or 1 M NaCl, which by themselves suppressed gastric motility, have no effect on gastric mucosa and on the inhibited gastric motility induced by necrotizing agents. Bandlike lesions were significantly prevented by pretreatment with 20% ethanol or 1 M NaCl but not with papaverine HCl or verapamil administered 30 min before necrotizing agents. The gastroprotection offered by 20% ethanol or 1 M NaCl was significantly diminished by pretreatment with subcutaneous indomethacin (30 mg/kg), but the inhibited gastric motility was not reversed by indomethacin. These results indicate that it seems unlikely that gastric contractile activity would play a major role in the development and prevention of gastric lesions after the administration of necrotizing agents.
在清醒大鼠中研究了坏死剂、胃动力阻滞剂和轻度刺激剂对胃黏膜和胃动力的影响。使用放置在胃腺部的微型气球记录胃运动活性,该气球连接到压力传感器和记录仪。坏死剂,如96%乙醇、0.6N盐酸、0.2N氢氧化钠或4M氯化钠,通过前胃瘘管经胃内给药。这些药剂1毫升可在胃体黏膜沿胃长轴产生出血带状病变,并伴有胃动力完全抑制(平滑肌松弛)。单独的胃动力阻滞剂,如皮下注射盐酸罂粟碱(50mg/kg)和腹腔注射维拉帕米(20mg/kg),或轻度刺激剂(1ml/只,口服),如20%乙醇或1M氯化钠,它们自身可抑制胃动力,但对胃黏膜以及坏死剂诱导的胃动力抑制没有影响。在坏死剂给药前30分钟用20%乙醇或1M氯化钠预处理可显著预防带状病变,但用盐酸罂粟碱或维拉帕米预处理则无效。皮下注射吲哚美辛(30mg/kg)预处理可显著减弱20%乙醇或1M氯化钠提供的胃保护作用,但吲哚美辛不能逆转胃动力抑制。这些结果表明,在给予坏死剂后,胃收缩活动似乎不太可能在胃病变的发生和预防中起主要作用。